Host Immune and Tissue Microenvironment

The **host immune and tissue microenvironment** refers to the dynamic composite of **immune cells** (both innate and adaptive, including tissue-resident subtypes[3]), **stromal cells**, **extracellular matrix components**, **vascular and endothelial structures**, and local signaling molecules within tissues[1][4][6]. These elements interact to regulate tissue homeostasis, surveillance, and responses to injury and disease, especially cancer. In the context of tumors, this microenvironment influences and is influenced by cancer cells, facilitating either **immune suppression or activation**, **angiogenesis**, **invasion**, and **metastasis**[4][2]. Tumor progression frequently involves complex bidirectional communication at the molecular and cellular levels, including remodeling of tissue structure, recruitment or exclusion of immune cells, and shifts in cytokine and chemokine signaling[6][1]. Differences in composition and organization across tissues and tumor types critically affect therapy response and disease outcome. Although the **host immune and tissue microenvironment** is a major research focus and acts as a barrier or facilitator for therapeutics, it is best described as a milieu or system rather than a single molecular target. Molecular targets within this environment include distinct receptors, enzymes, or signaling nodes, not the entire microenvironment as such[1][4][6].

Other names

Host tissue determinantsTumor microenvironment (TME)Immune microenvironmentTissue microenvironment